| CD200-CD200R pathway in the regulation of tumor immune microenvironment and immunotherapy JQ Liu, A Hu, J Zhu, J Yu, F Talebian, XF Bai Tumor Microenvironment: Signaling Pathways–Part A, 155-165, 2020 | 52 | 2020 |
| CD200 blockade modulates tumor immune microenvironment but fails to show efficacy in inhibiting tumor growth in a murine model of melanoma F Talebian, J Yu, K Lynch, JQ Liu, WE Carson, XF Bai Frontiers in Cell and Developmental Biology 9, 739816, 2021 | 10 | 2021 |
| Role of FABP5 in T cell lipid metabolism and function in the tumor microenvironment R Jin, J Hao, J Yu, P Wang, ER Sauter, B Li Cancers 15 (3), 657, 2023 | 8 | 2023 |
| IL-27 induces CCL5 production by T lymphocytes, which contributes to antitumor activity A Hu, J Zhu, C Zeng, CH Lin, J Yu, JQ Liu, K Lynch, F Talebian, X Pan, ... The Journal of Immunology 208 (9), 2239-2245, 2022 | 5 | 2022 |
| Is AAV-delivered IL-27 a potential immunotherapeutic for cancer? JQ Liu, J Zhu, A Hu, A Zhang, C Yang, J Yu, K Ghoshal, S Basu, XF Bai American Journal of Cancer Research 10 (11), 3565, 2020 | 5 | 2020 |
| Keratinocyte FABP5-VCP complex mediates recruitment of neutrophils in psoriasis J Hao, J Yu, MS Yorek, CL Yu, RM Pope, MS Chimenti, Y Xiong, ... Cell reports 42 (11), 2023 | 1 | 2023 |
| IL-27 Gene Therapy Induces Stat3-Mediated Expansion of CD11b+ Gr1+ Myeloid Cells and Promotes Accumulation of M1 Macrophages in the Tumor Microenvironment J Zhu, J Yu, A Hu, JQ Liu, X Pan, G Xin, WE Carson, Z Li, Y Yang, XF Bai The Journal of Immunology 211 (5), 895-902, 2023 | 1 | 2023 |
| Determination of the FABP5 expression profile in skin lesions of an IMQ-induced psoriasis mouse model using flow cytometry J Yu, J Hao, MS Yorek, X Han, A Avellino, X Jiang, S Liu, J Wang, B Li STAR protocols 5 (2), 103018, 2024 | | 2024 |
| Development of a humanized anti-FABP4 monoclonal antibody for treatment of breast cancer J Hao, R Jin, Y Yi, X Jiang, J Yu, Z Xu, NJ Schnicker, MS Chimenti, ... bioRxiv, 2024.05. 12.593748, 2024 | | 2024 |
